ID: ALA3594031

Max Phase: Preclinical

Molecular Formula: C23H17NO5

Molecular Weight: 387.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(COc1ccccc1)Nc1ccc(-c2coc3cc(O)ccc3c2=O)cc1

Standard InChI:  InChI=1S/C23H17NO5/c25-17-10-11-19-21(12-17)29-13-20(23(19)27)15-6-8-16(9-7-15)24-22(26)14-28-18-4-2-1-3-5-18/h1-13,25H,14H2,(H,24,26)

Standard InChI Key:  GDXCFLBCNWMCLR-UHFFFAOYSA-N

Associated Targets(non-human)

Cholesteryl ester transfer protein 233 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 387.39Molecular Weight (Monoisotopic): 387.1107AlogP: 4.18#Rotatable Bonds: 5
Polar Surface Area: 88.77Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.48CX Basic pKa: CX LogP: 3.79CX LogD: 2.84
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.54Np Likeness Score: -0.42

References

1. Wang W, He Y, Xu P, You Q, Xiao H, Xiang H..  (2015)  Synthesis and biological evaluation of isoflavone amide derivatives with antihyperlipidemic and preadipocyte antiproliferative activities.,  23  (15): [PMID:26145818] [10.1016/j.bmc.2015.06.032]

Source